The Food and Drug Administration has affixed a warning to the Johnson & Johnson coronavirus vaccine, saying the shot can lead to an increased risk of Guillain–Barré syndrome, a rare neurological condition.
Though the FDA said such instances are very rare, about 100 suspected cases have been identified among the nearly 13 million people who have received the shot, Axios reported.
No such connections have been made with any other available vaccines.
Meanwhile, Johnson & Johnson officials said its coronavirus vaccine is effective against the delta variant of the virus that health experts worry could cause another surge nationwide among the unvaccinated.
The company said last week that its one-dose shot defends against the variant, citing lab tests of vaccine recipients’ blood.
Company officials speculate the immune response may last more than eight months.
The FDA temporarily paused the distribution of the Johnson & Johnson vaccine in early April after concerns of a connection to a rare blood clotting condition, but rescinded the order less than two weeks later.
 

WI Guest Author

This correspondent is a guest contributor to The Washington Informer.

Leave a comment

Your email address will not be published.